| ORIGINAL ARTICLE |
|
| Year : 2016 | Volume
: 22
| Issue : 6 | Page : 448-455 |
|
|
Deoxyschizandrin suppresses dss-induced ulcerative colitis in mice
Wen-feng Zhang, Yan Yang, Xin Su, Da-yan Xu, Yu-li Yan, Qiao Gao, Ming-hua Duan
Changchun University of Chinese Medicine, Changchun Jingyue Street, Boshuo Road 1035, Changchun, Jilin, China
Correspondence Address:
Ming-hua Duan
Changchun University of Chinese Medicine, Changchun Jingyue Street, Boshuo Road
China
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/1319-3767.195552
|
|
|
Background/Aims: Deoxyschizandrin as one of the most important component of Schisandra chinensis (Turcz.) Baill plays an immunomodulatory role in a variety of diseases, yet its role in ulcerative colitis remains to be elucidated. We aimed to investigate the role of deoxyschizandrin in DSS-induced ulcerative colitis in mice. Patients and Methods: In the present study, an inflammation model of cells was constructed to confirm the anti-inflammatory effect of deoxyschizandrin. Then a mouse model with Dextran sulfate sodium sulfate (DSS)-induced ulcerative colitis was constructed, and the effects of deoxyschizandrin on mouse colon inflammation, apoptosis, and CD4 T lymphocyte infiltration in ulcerative colitis were examined. Result: Deoxyschizandrin could improve the symptoms of ulcerative colitis, determined by hematoxylin-eosin (HE) staining and histopathological scores. Moreover, deoxyschizandrin reduced the levels of inflammatory cytokines, suppressed CD4 T cell infiltration, and effectively inhibited apoptosis in the colon of DSS-induced ulcerative colitis mice. Conclusion: In summary, deoxyschizandrin can effectively rescue the symptoms of DSS-induced ulcerative colitis in mice by inhibiting inflammation. T cell infiltration and apoptosis in the colon, suggesting that deoxyschizandrin could be a potential drug in treating ulcerative colitis. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
